You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 21, 2025

Drug Price Trends for NAPROXEN DR


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for NAPROXEN DR

Average Pharmacy Cost for NAPROXEN DR

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
NAPROXEN DR 375 MG TABLET 69543-0425-10 1.10590 EACH 2024-12-18
NAPROXEN DR 375 MG TABLET 00093-1005-01 1.10590 EACH 2024-12-18
NAPROXEN DR 375 MG TABLET 70954-0925-10 1.10590 EACH 2024-12-18
NAPROXEN DR 500 MG TABLET 70954-0928-10 1.73105 EACH 2024-12-18
NAPROXEN DR 375 MG TABLET 00093-1005-05 1.10590 EACH 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Naproxen

Introduction to Naproxen

Naproxen, a non-steroidal anti-inflammatory drug (NSAID), is widely used for its analgesic, anti-inflammatory, and antipyretic properties. It is commonly prescribed for conditions such as arthritis, menstrual cramps, and other types of pain.

Global Market Overview

The global naproxen market is part of the larger NSAIDs market, which was valued at USD 15.58 billion in 2019 and is projected to reach USD 32.33 billion by 2032[3].

Market Size and Growth

The global naproxen market size in 2023 was significant, although the exact figure is not specified. However, the market is expected to grow at a compound annual growth rate (CAGR) from 2024 to 2031[1].

Regional Analysis

  • North America: This region holds the highest market share in the NSAIDs market, with a value of USD 6.86 billion in 2019. It is expected to continue its dominance due to high demand and the presence of major pharmaceutical companies like GlaxoSmithKline plc and Pfizer Inc.[3].
  • Europe: The European market, particularly Germany, has shown robust pricing trends driven by seasonal demand and economic factors such as currency fluctuations and logistics challenges[4].
  • Asia-Pacific: This region experienced significant disruptions in the naproxen market in 2024, primarily due to congestion at major coastal ports in China, leading to supply chain bottlenecks and increased prices[4].

Price Trends

Current Pricing

The prices of naproxen vary widely depending on the dosage form and quantity. For example:

  • 250 mg oral tablets: Prices range from $0.30 to $1.79 per unit, depending on the quantity purchased[2].
  • Naproxen Sodium: The price in the USA was around $35,550 USD/MT in March 2024, while in Europe it was approximately $36,850 USD/MT[4].

Historical Price Trends

  • 2023: In the first two quarters, naproxen sodium prices in Asia showed an upward trajectory due to increased orders from domestic and international buyers. However, in the third quarter, the prices declined due to weak demand and grim economic conditions[4].
  • 2024: The first quarter saw a decline in naproxen sodium prices globally due to subdued demand and fluctuations in production expenses. In contrast, the North American market experienced a steady upward trajectory in prices driven by supply constraints and elevated production costs[4].

Factors Influencing Prices

Supply Chain Disruptions

Supply chain disruptions, such as congestion at Chinese ports, natural disasters, and geopolitical factors, have significantly impacted the availability and cost of naproxen. These disruptions have led to higher transportation costs and tighter supply conditions, resulting in price increases[4].

Economic Factors

Currency fluctuations, logistics challenges, and changes in production costs have also influenced the pricing of naproxen. For instance, the European market has seen robust pricing trends due to these economic factors[4].

Demand and Market Conditions

The demand for naproxen is driven by the rising prevalence of chronic pain and a preference for NSAIDs over opioids. However, subdued demand from downstream industries and surplus inventories have led to price declines in certain regions[3][4].

Market Projections

Forecasted Growth

The NSAIDs market, including naproxen, is projected to grow at a CAGR of 5.8% from 2020 to 2027. By 2032, the market is expected to reach USD 32.33 billion[3].

Price Projections

Given the ongoing global supply chain uncertainties and potential geopolitical and economic shifts, the naproxen market is expected to remain volatile. Prices are likely to oscillate based on market demands and global economic conditions. However, the overall trend suggests a potential increase in prices due to rising demand and production costs[4].

Key Players and Market Competition

Major pharmaceutical companies such as GlaxoSmithKline plc and Pfizer Inc. dominate the NSAIDs market. These companies play a significant role in shaping market trends and pricing strategies[3].

Technological and Research Trends

Research on developing selective COX-2 inhibitors is a key trend in the NSAIDs market. This research aims to reduce the gastrointestinal side effects associated with traditional NSAIDs, which could influence future market dynamics and pricing[3].

Consumer Behavior and Preferences

The preference for NSAIDs over opioids due to their lower risk of addiction and side effects is a significant driver of the market. Consumer behavior, particularly the increasing awareness of health and wellness, also influences the demand for naproxen and other NSAIDs[1][3].

Regulatory and Environmental Factors

Regulatory changes and environmental, social, and governance (ESG) factors can impact the production and pricing of naproxen. For instance, changes in regulatory policies or increased scrutiny on pharmaceutical manufacturing practices can affect market conditions[1].

"Rising prevalence of chronic pain and preference for NSAIDs over opioids are the key factors driving the market."[3]

Key Takeaways

  • The global naproxen market is part of the larger NSAIDs market, projected to grow significantly by 2032.
  • Regional markets such as North America and Europe are key drivers of the naproxen market.
  • Supply chain disruptions, economic factors, and demand conditions significantly influence naproxen prices.
  • Major pharmaceutical companies dominate the market and drive pricing strategies.
  • Research on selective COX-2 inhibitors is a key trend in the NSAIDs market.

FAQs

1. What is the current market size of the global naproxen market? The exact current market size of the global naproxen market is not specified, but it is part of the larger NSAIDs market valued at USD 15.58 billion in 2019[3].

2. What are the key factors driving the naproxen market? The rising prevalence of chronic pain and the preference for NSAIDs over opioids are key drivers of the market[3].

3. How do supply chain disruptions affect naproxen prices? Supply chain disruptions, such as port congestion and natural disasters, lead to higher transportation costs and tighter supply conditions, resulting in price increases[4].

4. Which regions dominate the naproxen market? North America and Europe are significant regions in the naproxen market, with North America holding the highest market share[3][4].

5. What are the future price projections for naproxen? Prices are expected to remain volatile due to global supply chain uncertainties and economic shifts, but there is a potential for overall price increases driven by rising demand and production costs[4].

Sources

  1. Cognitivemarketresearch.com: Naproxen Market Report 2024 (Global Edition)
  2. Drugs.com: Naproxen Prices, Coupons, Copay Cards & Patient Assistance
  3. Fortunebusinessinsights.com: Non-steroidal Anti-Inflammatory Drugs [NSAIDs] Market Size By 2032
  4. Procurementresource.com: Naproxen Sodium Price Trend and Forecast
  5. ChemAnalyst.com: Naproxen Prices, News, Monitor, Market Analysis & Demand

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.